Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 40

1.

Outcomes of switching anti-TNF drugs in rheumatoid arthritis--a study based on observational data from the Finnish Register of Biological Treatment (ROB-FIN).

Virkki LM, Valleala H, Takakubo Y, Vuotila J, Relas H, Komulainen R, Koivuniemi R, Yli-Kerttula U, Mali M, Sihvonen S, Krogerus ML, Jukka E, Nyrhinen S, Konttinen YT, Nordström DC.

Clin Rheumatol. 2011 Nov;30(11):1447-54. doi: 10.1007/s10067-011-1779-1. Epub 2011 Jun 7.

PMID:
21644062
2.

Cost of Finnish statutory inpatient rehabilitation and its impact on functional and work capacity of patients with early rheumatoid arthritis: experience from the FIN-RACo trial.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Pohjolainen T, Korpela M, Vuori K, Ilva K, Yli-Kerttula U, Järvinen P, Leirisalo-Repo M.

Scand J Rheumatol. 2007 Jul-Aug;36(4):270-7.

PMID:
17763204
3.

Indoleamine 2,3-dioxygenase activity is increased in patients with systemic lupus erythematosus and predicts disease activation in the sunny season.

Pertovaara M, Hasan T, Raitala A, Oja SS, Yli-Kerttula U, Korpela M, Hurme M.

Clin Exp Immunol. 2007 Nov;150(2):274-8. Epub 2007 Aug 17.

4.

Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study.

Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Hakala M, Korpela M, Ilva K, Yli-Kerttula U, Piirainen H, Leirisalo-Repo M; FIN-RACo Trial Troup.

Ann Rheum Dis. 2005 Jan;64(1):130-3.

5.

Seasonal variation of disease activity of systemic lupus erythematosus in Finland: a 1 year follow up study.

Hasan T, Pertovaara M, Yli-Kerttula U, Luukkaala T, Korpela M.

Ann Rheum Dis. 2004 Nov;63(11):1498-500.

6.

HLA-DR-DQ haplotypes and genotypes in Finnish patients with rheumatoid arthritis.

Laivoranta-Nyman S, Möttönen T, Hermann R, Tuokko J, Luukkainen R, Hakala M, Hannonen P, Korpela M, Yli-Kerttula U, Toivanen A, Ilonen J; FIN-RACo Trial Group.

Ann Rheum Dis. 2004 Nov;63(11):1406-12.

7.

Effect of a three month course of ciprofloxacin on the late prognosis of reactive arthritis.

Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, Sanila M, Uksila J, Toivanen A.

Ann Rheum Dis. 2003 Sep;62(9):880-4.

8.

Mononuclear cell response to enterobacteria and Gram-positive cell walls of normal intestinal microbiota in early rheumatoid arthritis and other inflammatory arthritides.

Chen T, Rimpiläinen M, Luukkainen R, Möttönen T, Yli-Kerttula U, Saario R, Toivanen P.

Clin Exp Rheumatol. 2002 Mar-Apr;20(2):193-200.

PMID:
12051398
9.

Differences between female and male patients with familial rheumatoid arthritis.

Laivoranta-Nyman S, Luukkainen R, Hakala M, Hannonen P, Möttönen T, Yli-Kerttula U, Ilonen J, Toivanen A.

Ann Rheum Dis. 2001 Apr;60(4):413-5.

10.

Effect of a three month course of ciprofloxacin on the outcome of reactive arthritis.

Yli-Kerttula T, Luukkainen R, Yli-Kerttula U, Möttönen T, Hakola M, Korpela M, Sanila M, Parviainen J, Uksila J, Vainionpää R, Toivanen A.

Ann Rheum Dis. 2000 Jul;59(7):565-70.

11.

Immunogenetic differences between patients with familial and non-familial rheumatoid arthritis.

Laivoranta-Nyman S, Möttönen T, Luukkainen R, Hakala M, Yli-Kerttula U, Hannonen P, Tuokko J, Toivanen A, Ilonen J.

Ann Rheum Dis. 2000 Mar;59(3):173-7.

12.

Comparison of combination therapy with single-drug therapy in early rheumatoid arthritis: a randomised trial. FIN-RACo trial group.

Möttönen T, Hannonen P, Leirisalo-Repo M, Nissilä M, Kautiainen H, Korpela M, Laasonen L, Julkunen H, Luukkainen R, Vuori K, Paimela L, Blåfield H, Hakala M, Ilva K, Yli-Kerttula U, Puolakka K, Järvinen P, Hakola M, Piirainen H, Ahonen J, Pälvimäki I, Forsberg S, Koota K, Friman C.

Lancet. 1999 May 8;353(9164):1568-73.

PMID:
10334255
13.

A randomized, double-blind, placebo-controlled study of moclobemide and amitriptyline in the treatment of fibromyalgia in females without psychiatric disorder.

Hannonen P, Malminiemi K, Yli-Kerttula U, Isomeri R, Roponen P.

Br J Rheumatol. 1998 Dec;37(12):1279-86.

PMID:
9973149
14.

Tumour necrosis factor microsatellites in reactive arthritis.

Tuokko J, Koskinen S, Westman P, Yli-Kerttula U, Toivanen A, Ilonen J.

Br J Rheumatol. 1998 Nov;37(11):1203-6.

PMID:
9851270
15.

TAP2 alleles in inflammatory arthritis.

Tuokko J, Pushnova E, Yli-Kerttula U, Toivanen A, Ilonen J.

Scand J Rheumatol. 1998;27(3):225-9.

PMID:
9645419
16.

Ligase chain reaction in detection of Chlamydia DNA in synovial fluid cells.

Nikkari S, Puolakkainen M, Yli-Kerttula U, Luukkainen R, Lehtonen OP, Toivanen P.

Br J Rheumatol. 1997 Jul;36(7):763-5.

PMID:
9255110
17.

Detection of rubella, mumps, and measles virus genomic RNA in cells from synovial fluid and peripheral blood in early rheumatoid arthritis.

Zhang D, Nikkari S, Vainionpää R, Luukkainen R, Yli-Kerttula U, Toivanen P.

J Rheumatol. 1997 Jul;24(7):1260-5.

PMID:
9228121
18.

Reactive arthritis in a patient with simultaneous parvovirus B19 infection and Clostridium difficile diarrhoea.

Nikkari S, Yli-Kerttula U, Toivanen P.

Br J Rheumatol. 1997 Jan;36(1):143-4. No abstract available.

PMID:
9117160
19.

Increase of HLA-DRB1*0408 and -DQB1*0301 in HLA-B27 positive reactive arthritis.

Tuokko J, Reijonen H, Ilonen J, Anttila K, Nikkari S, Möttönen T, Yli-Kerttula U, Toivanen A.

Ann Rheum Dis. 1997 Jan;56(1):37-40.

20.

Peripheral blood neutrophil leukotriene B4 release and migration in rheumatoid arthritis.

Kankaanranta H, Moilanen E, Tuomiranta T, Korpela M, Yli-Kerttula U, Isomäki H, Vapaatalo H.

Inflammation. 1996 Oct;20(5):513-22.

PMID:
8894715
21.

Predictive value of synovial fluid analysis in estimating the efficacy of intra-articular corticosteroid injections in patients with rheumatoid arthritis.

Luukkainen R, Hakala M, Sajanti E, Huhtala H, Yli-Kerttula U, Hämeenkorpi R.

Ann Rheum Dis. 1992 Jul;51(7):874-6.

22.

Salmonella specific antibodies in serum and synovial fluid in patients with reactive arthritis.

Mäki-Ikola O, Yli-Kerttula U, Saario R, Toivanen P, Granfors K.

Br J Rheumatol. 1992 Jan;31(1):25-9.

PMID:
1730101
23.

AB0 and Lewis blood groups in reactive arthritis.

Tertti R, Järvinen H, Lahesmaa R, Yli-Kerttula U, Toivanen A.

Rheumatol Int. 1992;12(3):103-5.

PMID:
1411088
24.

Nervous system manifestations in Sjögren's syndrome.

Hietaharju A, Yli-Kerttula U, Häkkinen V, Frey H.

Acta Neurol Scand. 1990 Feb;81(2):144-52.

PMID:
2327235
25.

Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial.

Nissilä M, Lehtinen K, Leirisalo-Repo M, Luukkainen R, Mutru O, Yli-Kerttula U.

Arthritis Rheum. 1988 Sep;31(9):1111-6.

PMID:
2901839
26.

Urogenital involvements and rheumatic disorders in females. An interview study.

Yli-Kerttula UI, Kataja MJ, Vilppula AH.

Clin Rheumatol. 1985 Jun;4(2):170-5.

PMID:
4006385
27.

Infectious involvements in males with Reiter's syndrome.

Vilppula AH, Granfors KM, Yli-Kerttula UI.

Clin Rheumatol. 1984 Dec;3(4):443-9.

PMID:
6549275
28.

Clinical characteristics in male and female uro-arthritis or Reiter's syndrome.

Yli-Kerttula UI.

Clin Rheumatol. 1984 Sep;3(3):351-60.

PMID:
6488714
29.

The nature of urogenital involvements in female uro-arthritis, with special reference to chlamydial infection.

Yli-Kerttula UI, Selander KK, Terho PE, Kataja JM, Vilppula AH.

Clin Rheumatol. 1984 Jun;3(2):155-62.

PMID:
6467859
30.

Salpingitis and cervicitis in uro-arthritis.

Yli-Kerttula UI, Kataja JM, Vilppula AH.

Clin Rheumatol. 1984 Jun;3(2):169-72.

PMID:
6331973
31.

Rheumatic salpingitis?

Yli-Kerttula UI, Vilppula AH.

Clin Rheumatol. 1984 Mar;3(1):85-6. No abstract available.

PMID:
6467856
32.

Reiter's syndrome in male sexual partners of females with Reiter's syndrome or suspicion of it.

Vilppula AH, Terho PE, Yli-Kerttula UI.

Clin Rheumatol. 1983 Dec;2(4):353-6.

PMID:
6678195
33.

Musculoskeletal involvements in female sexual partners of males with Reiter's syndrome.

Vilppula AH, Granfors KM, Terho PE, Yli-Kerttula UI.

Clin Rheumatol. 1983 Dec;2(4):347-52.

PMID:
6678194
34.

Urogenital involvements in female sexual partners of males with Reiter's syndrome.

Vilppula AH, Yli-Kerttula UI, Selander KK, Terho PE.

Clin Rheumatol. 1983 Dec;2(4):339-45.

PMID:
6378493
35.

Sebaceous glands in the buccal mucosa in patients with rheumatic disorders.

Vilppula AH, Yli-Kerttula UI, Terho PE, Aine RA, Estola EJ.

Scand J Rheumatol. 1983;12(4):337-42.

PMID:
6658396
36.
37.

Pigmented villonodular synovitis (PVS) A case report.

Vilppula AH, Yli-Kerttula UI, Aine RA, Ojala AT.

Scand J Rheumatol. 1982;11(3):145-9. No abstract available.

PMID:
7123175
38.

Chlamydial infection in a family.

Yli-Kerttula UI, Saari KM, Terho PE, Selander KK, Vilppula AH.

Scand J Rheumatol. 1982;11(4):235-8.

PMID:
6983717
39.

Reiter's syndrome in the population. An Interview Study.

Vilppula AH, Yli-Kerttula UI, Terho PE.

Scand J Rheumatol. 1982;11(3):150-4.

PMID:
6896930
40.

Chlamydial isolations and serology in Reiter's syndrome.

Vilppula AH, Yli-Kerttula UI, Ahlroos AK, Terho PE.

Scand J Rheumatol. 1981;10(3):181-5.

PMID:
7291951

Supplemental Content

Loading ...
Support Center